Cordlife Group Limited (P8A)
Replace - Financial Statements and Related Announcement :: Third Quarter Results
Replace - Financial Statements and Related Announcement :: Third Quarter Results
Biotricity strengthens path to scalable profitability for second quarter Fiscal 2026 with sustained margins & operational efficiency
Shareholder Alert: The Ademi Firm investigates whether Cidara Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
Financial Statements and Related Announcement :: Third Quarter Results
Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S
Curis to Present at Upcoming 30th Annual SNO Meeting
New SEC Form for ResMed Inc.
Indivior Notification
Forte Biosciences Inc - Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates